Searchable abstracts of presentations at key conferences in endocrinology

ea0030oc1.7 | Oral Communications 1 | BSPED2012

Novel therapies herald novel diseases: The first paediatric case series of Graves' immune reconstitution disease

Sinha Akash , Abinun Mario , Cheetham Tim

Introduction: The use of haematopoietic stem cell transplantation (HSCT) as a curative therapy for life threatening immunodeficiency signalled a paradigm shift in clinical outcomes. However, a subset of patients may experience Thyroid Immune Reconstitution Inflammatory Syndrome (IRIS) following immune reconstitution. This is recognised in the adult population but has received little attention in the paediatric literature. We present, what we believe to be, the first case serie...

ea0077oc6.1 | Thyroid | SFEBES2021

Adjuvant Rituximab – exploratory trial in young people with Graves’ disease

Cheetham Tim , Cole Michael , Abinun Mario , Alalhabadia Amit , Barratt Tim , Davies Justin , Dimitri Paul , Drake Amanda , Mohamed Zainaba , Murray Robert , Steele Caroline , Zammitt Nicola , Carnell Sonya , Prichard Jonathan , Watson Gillian , Hambleton Sophie , Matthews John , Pearce Simon

Objective: Remission rates in young people with GravesÂ’ hyperthyroidism are <25% after a 2-yr course of thionamide antithyroid drug (ATD). Immunomodulatory agents might improve outcome by facilitating immune tolerance. We explored whether rituximab (RTX) would increase remission rates when administered with a short course of ATD.Design: This was an open label multi-centre single arm phase 2 trial in newly presenting young people (12-20y) with Gr...